非顺应性球囊治疗下肢慢性肢体威胁性缺血的前瞻性研究结局
这项在新加坡某三级医院开展的前瞻性单中心队列研究,纳入50例(50条肢体)因慢性肢体威胁性缺血(CLTI)接受非顺应性球囊下肢血管成形术的患者,病变为TASC C/D且长度至少100mm。12个月无截肢生存率为70.0%,免于临床驱动靶病变血运重建率为90.1%,靶病变一期通畅率为61.1%。作者认为早期结果示高压非顺应性球囊有效,但需等待更长期通畅结果。
要点
- 50例CLTI患者(50条肢体)接受非顺应性球囊下肢血管成形术,技术成功率96.5%。
- 12个月无截肢生存率70.0%,免于cdTLR率90.1%,靶病变一期通畅率61.1%。
- 术后30天1例死于急性心肌梗死,2例腹股沟血肿保守治疗。
核心结论
- 早期结果显示高压非顺应性球囊用于高比例长段膝下病变的CLTI患者下肢血管成形术有效,可获得良好血管通畅率和保肢率且并发症率低。
- 作者表示尚需等待更多关于血管通畅性的长期结局。
研究设计与样本
- 前瞻性单中心队列研究,在新加坡某三级医院开展。
- 连续纳入年龄40岁及以上、Rutherford 4至6级CLTI、下肢血管TASC C或D病变且长度至少100mm、使用非顺应性球囊导管行下肢血管成形术的患者。
- 2020年5月至2021年12月共纳入50例患者(50条肢体),治疗85处病变。
主要发现
- 43例(86%)患者有糖尿病,12例(24%)有终末期肾衰竭。
- 85处病变中膝下病变59处(69.4%),TASC C病变45处(52.9%)、TASC D病变40处(47.1%),平均病变长度231.4±116.2mm。
- 技术成功率96.5%,无患者失访,中位随访282天(IQR:31-390天)。
- 术后12个月无截肢生存率70.0%(95%CI:58.4%-83.9%),免于临床驱动靶病变血运重建率90.1%(95%CI:83.4%-97.4%),靶病变一期通畅率61.1%(95%CI:50.7%-73.6%)。
- 术后第26天1例患者因急性心肌梗死死亡,术后2例患者出现腹股沟血肿,均保守治疗。
临床怎么用
- 作者认为非顺应性球囊使用技术上简单,与标准普通球囊血管成形术(POBA)相比不增加额外步骤,从而限制费用。
- 作者认为本文可推动临床医生在患者诊疗中考虑使用这些高压非顺应性球囊。
局限性
- 作者表示尚需等待更多关于血管通畅性的长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This is a prospective study to investigate the clinical outcomes of using noncompliant balloons in lower limb angioplasty for chronic limb threatening ischemia (CLTI). MATERIALS AND METHODS: This is a prospective single-center cohort study performed at a local tertiary hospital in Singapore. Consecutive patients who underwent lower limb angioplasty for CLTI using a noncompliant balloon catheter were enrolled if they were aged 40 years and above, presented with CLTI Rutherford grade 4 to 6, and had TASC C or D lesions in the lower limb vessels that were at least 100mm in length. Patient demographics, Rutherford grading, lesion characteristics, complications, and follow-up data were collected and analyzed. The primary outcomes were 30-day freedom from major adverse events, amputation-free survival (AFS) at 12 months, and freedom from clinically driven target lesion revascularization (cdTLR) at 12 months. Secondary outcomes included clinical success and target lesion primary patency (TLPP) at 12 months. Amputation-free survival, freedom from cdTLR, and TLPP were calculated by Kaplan-Meier analysis. RESULTS: From May 2020 to December 2021, 50 patients (50 limbs) were enrolled. 43 (86%) patients had diabetes mellitus, while 12 patients (24%) had end-stage renal failure. 85 lesions were treated, including 59 (69.4%) below-the-knee (BTK) lesions. All the lesions were TASC C (n=45, 52.9%) or TASC D (n=40, 47.1%) lesions. Mean lesion length was 231.4±116.2mm. Technical success rate was 96.5%. No patients were lost to follow-up. Median follow-up duration was 282 days (IQR: 31-390 days). One patient died on day 26 due to an acute myocardial infarction. Two patients had groin hematomas postprocedure, both of which were treated conservatively. AFS, freedom from cdTLR, and TLPP at 12 months postprocedure was 70.0% (95% confidence interval [CI]: 58.4%-83.9%), 90.1% (95% CI: 83.4%-97.4%), and 61.1% (95% CI: 50.7%-73.6%), respectively. CONCLUSION: Early results have shown that the use of a high-pressure, noncompliant balloon is effective in lower limb angioplasty for CLTI in a highly challenging group of patients with a high prevalence of long BTK disease. Good vessel patency and limb salvage rates can be achieved, with a low complication rate. We await more long-term outcomes on vessel patency.Clinical ImpactThere are many devices in the market for use in lower limb angioplasty. However, many of them come with an increased financial cost, procedural time and procedural difficulty. We report our prospective results with the exclusive use of a high pressure, non-compliant balloon, in a challening group of patients with a high prevalence of diabetes and end stage renal failure, achieving amputation free surival at 6 and 12 months post-procedure of 84.0% and 70.0% respectively. The use of non-compliant balloon is technically easy and does not add additional steps compared to a standard POBA procedure, thus limiting costs. We believe this article can be a push factor for clinicians to consider the use of these high pressure, non-compliant balloons in their patient care.
引用
- Yap HY, Tang TY, Yap C, et al. Outcomes of Noncompliant Balloons in the Treatment of Lower Extremity Chronic Limb Threatening Ischemia: A Prospective Study. J Endovasc Ther. 2024. PMID: 39126223. doi:10.1177/15266028241268828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。